1. Home
  2. PRME vs VTMX Comparison

PRME vs VTMX Comparison

Compare PRME & VTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRME
  • VTMX
  • Stock Information
  • Founded
  • PRME 2019
  • VTMX 1998
  • Country
  • PRME United States
  • VTMX Mexico
  • Employees
  • PRME N/A
  • VTMX N/A
  • Industry
  • PRME Medicinal Chemicals and Botanical Products
  • VTMX
  • Sector
  • PRME Health Care
  • VTMX
  • Exchange
  • PRME Nasdaq
  • VTMX Nasdaq
  • Market Cap
  • PRME 191.7M
  • VTMX 2.3B
  • IPO Year
  • PRME 2022
  • VTMX 2023
  • Fundamental
  • Price
  • PRME $4.79
  • VTMX $25.18
  • Analyst Decision
  • PRME Buy
  • VTMX Sell
  • Analyst Count
  • PRME 6
  • VTMX 2
  • Target Price
  • PRME $9.38
  • VTMX $29.00
  • AVG Volume (30 Days)
  • PRME 5.1M
  • VTMX 153.6K
  • Earning Date
  • PRME 08-04-2025
  • VTMX 07-24-2025
  • Dividend Yield
  • PRME N/A
  • VTMX 2.53%
  • EPS Growth
  • PRME N/A
  • VTMX N/A
  • EPS
  • PRME N/A
  • VTMX 0.13
  • Revenue
  • PRME $3,846,000.00
  • VTMX $258,927,122.00
  • Revenue This Year
  • PRME $104.12
  • VTMX $17.35
  • Revenue Next Year
  • PRME $108.24
  • VTMX $11.82
  • P/E Ratio
  • PRME N/A
  • VTMX $19.22
  • Revenue Growth
  • PRME 550.76
  • VTMX 15.06
  • 52 Week Low
  • PRME $1.11
  • VTMX $21.30
  • 52 Week High
  • PRME $6.75
  • VTMX $32.84
  • Technical
  • Relative Strength Index (RSI)
  • PRME 79.55
  • VTMX 27.96
  • Support Level
  • PRME $4.01
  • VTMX $25.41
  • Resistance Level
  • PRME $4.83
  • VTMX $27.65
  • Average True Range (ATR)
  • PRME 0.46
  • VTMX 0.47
  • MACD
  • PRME 0.18
  • VTMX -0.17
  • Stochastic Oscillator
  • PRME 84.51
  • VTMX 11.61

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

About VTMX Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

Corporacion Inmobiliaria Vesta SAB de CV is an internally managed real estate company that owns, manages, develops, and leases industrial properties in Mexico. The Company's primary business is the acquisition, development, and management of industrial and distribution center real estate. The company designs and constructs park-to-suit projects across various industries; undertakes build-to-suit projects; and provides site selection, design and engineering, and sale and leaseback services. The primary source of revenue is the rental income received from customers under operating leases. It serves aerospace, automotive, food and beverage, logistics, medical devices, plastics, and other industries.

Share on Social Networks: